Please assess the completion status of the following clinical trial:

Trial Title: Russian Registry of Patients With nAMD

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age \> to 18 years~* Male or female patients diagnosed with nAMD (with or without previous treatment for nAMD including but not limited to PDT, laser coagulation, vitamins, retinolamine, emoxipine, anti-VEGF therapy or any surgery for nAMD).~* Willing and able to provide informed written consent personally or by legal proxy~Exclusion Criteria:~* The patient does not meet the inclusion criteria;~* The patient is simultaneously participating in a different nAMD therapy study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- nAMD patients (Type: None): patients diagnosed with Neovascular Age-Related Macular Degeneration

Based on this trial design, predict the completion outcome and termination type (if applicable).